Patient Specific QA for External Beam Radiotherapy Using the HYPERSCINT Plastic Scintillation Detector

Plastic scintillation detectors (PSDs) have interesting dosimetric properties, including small size and energy independence. These advantages make them well suited for VMAT patient-specific QA, either alone or in conjunction with a detector matrix. This work aims to determine if the HYPERSCINT scintillation dosimetry research platform (Medscint inc., Quebec city, Canada) can replace the classic ion chamber in a clinical patient-specific QA workflow.

2020 AAPM AM
M.Goulet | CISSS – Chaudiere-Appalaches, Lévis, QC, CA

Small field dosimetry of a Varian TrueBeam High Definition MLC linear accelerator using theHyperscint RP200 scintillation detector.

To evaluate the performance of the new Hyperscint RP200 plastic scintillator for small field measurements of a Varian TrueBeam linear accelerator in comparison with the current state-of-the-art methodology in the clinic.

2021 COMP ASM
L.Gingras, B.Côté, F.Berthiaume, S.Lambert-Girard, D.Leblanc, L.Archambault, L.Beaulieu, F.Therriault-Proulx | CHU de Quebec – Universite Laval, QC, CA, Département de radio-oncologie et Axe Oncologie du CRCHU de Québec, QC, CA, MedScint, QC, CA